SAREPTA THERAPEUTICS INC (SRPT)

US8036071004 - Common Stock

128.77  +1.38 (+1.08%)

After market: 128.77 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.24B933.00M701.90M540.10M380.80M
Cost Of Goods
150.34M140.00M97.00M63.40M56.60M
Gross Profit
1.09B793.00M604.80M476.70M324.20M
Operating Expenses
1.36B1.33B1.05B1.04B846.60M
Research and Development
877.39M877.10M771.20M722.30M560.90M
Selling, General, and Administrative Expenses
481.87M451.40M282.70M317.90M284.80M
Operating Income
-267.82M-536.20M-449.70M-564.20M-522.40M
Interest Income/Expense
13.05M-30.10M-56.00M-102.00MN/A
Other Income/Expense
50.33M4.30M-800.00K5.00M-8.30M
Non Recurring Items
-315.65M-128.00M87.50M108.10M-183.20M
Income Before Taxes
-520.10M-690.00M-418.90M-553.10M-713.90M
Income Tax
15.88M13.50M-200.00K1.10M1.20M
Net Income
-535.98M-703.50M-418.80M-554.10M-715.10M
EBITDA
-223.43M-494.30M-411.70M-537.30M-491.90M
 
Per Share Data
EPS Diluted Total Ops
-5.80-8.03-5.15-7.11-9.71
Non GAAP EPS
-6.12-8.03-6.01-6.49-7.32
 
Statistics
Gross Profit Margin
87.91%84.99%86.17%88.26%85.14%
Profit Margin
-43.11%-75.40%-59.67%-102.59%-187.79%
Operating Profit Margin
-21.54%-57.47%-64.07%-104.46%-137.18%

All data in USD

Charts